Table 1.
Ovarian cancer clinical data
| Duke |
Moffitt |
|||||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| Age | ||||||
| <45 | 2 | 5.7 | 2 | 10.0 | ||
| 45−55 | 8 | 22.9 | 5 | 25.0 | ||
| 55−65 | 11 | 31.4 | 7 | 35.0 | ||
| 65−75 | 11 | 31.4 | 4 | 20.0 | ||
| >=75 | 3 | 8.6 | 2 | 10.0 | ||
| Mean/Min/Max | 60/33/79 | 59/33/76 | ||||
| Stage | ||||||
| III | 31 | 88.6 | 14 | 70.0 | ||
| IV | 4 | 11.4 | 6 | 30.0 | ||
| Grade | ||||||
| I | 1 | 2.9 | 2 | 10.0 | ||
| II | 15 | 42.9 | 3 | 15.0 | ||
| III | 19 | 54.3 | 15 | 75.0 | ||
| DFS interval (mo.) | ||||||
| <12 | 24 | 68.6 | 12 | 60.0 | ||
| >=12 | 11 | 31.4 | 8 | 40.0 | ||
| Mean/Min/Max | 20.0/0.0/156.0 | 12.1/0.0/44.0 | ||||
| Surgical debulking | ||||||
| Suboptimal (>1 cm) | 21 | 60.0 | 4 | 20.0 | ||
| Optimal (<1 cm) | 14 | 40.0 | 16 | 80.0 | ||
| Platinum response | ||||||
| Yes | 22 | 68.9 | 4 | 20.0 | ||
| Partial | 8 | 22.9 | 16 | 80.0 | ||
| No/Stable disease | 5 | 14.3 | 0 | 0.0 | ||
| Survival time (mo.) | ||||||
| Observed | 30 | 85.7 | 6 | 30.0 | ||
| Censored | 5 | 14.3 | 14 | 70.0 | ||
| Mean/Min/Max | 55.3/6.0/185.0 | 39.0/11.0/101.0 | ||||
DFS = disease-free survival.